# Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain

> **NCT01384292** · PHASE3 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 14 (actual)

## Conditions studied

- Opioid-Induced Constipation

## Interventions

- **DRUG:** NKTR-118
- **DRUG:** NKTR-118
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01384292
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** The study was stopped early due to recruitment challenges
- **Last updated:** 2015-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01384292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01384292, "Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01384292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*